<DOC>
	<DOC>NCT02940210</DOC>
	<brief_summary>A randomized, single-blind, multi-center, Phase III clinical trial to evaluate the efficacy and safety of adhesion barrier Mediclore versus no treatment in patients with total thyroidectomy</brief_summary>
	<brief_title>Clinical Trial to Evaluate the Efficacy and Safety of Adhesion Barrier Mediclore Versus no Treatment in Patients With Total Thyroidectomy</brief_title>
	<detailed_description />
	<criteria>Written informed consent Male or female at least 20 years of age Patients without clinically significant lab Patients scheduled for thyroidectomy Another clinical trials within 1 month History of previous surgery on same position Anticoagulant, general steroids within a week from surgery Immunosuppression or autoimmune disease General or local infection Serious diseases (heart failure, renal failure, liver failure, uncontrolled hypertension, diabetes mellitus, coagulation deficiencies) Incompatible medications History of drug or alcohol abuse, mental disorder Pregnant or lactating women and fertile women who is not using proper contraceptive method History of esophagus diseases Keloid symptoms</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>